ArticleJournal of clinical medicine2022
Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results.
Maurizio Valeriani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it